Info received about 美国阿尔尼拉姆生物技术公司, 核糖核酸干扰(RNAi)疗法 ALN-VSP.
Further search found the pharmaceutical company Alnylam and multiple reports (1, 2, 3, 4) on positive results from ALN-VSP treatment on primary or secondary liver cancer, though no report found on related treatment for glioma or DIPG.